Medications

Budesonide yields durable reduction in eGFR for IgA nephropathy

For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...

Cardiology

Reduced eGFR linked to increased mortality in A-fib

Moderately-to-severely reduced estimated glomerular filtration rate (eGFR) is associated with increased risk of all-cause mortality in patients with atrial fibrillation (AF), specifically among those with lower socioeconomic ...

page 2 from 18